Selected research
Industry Research
Organ Preservation Solutions Industry Research Report 2026
Market perspective
The global Organ Preservation Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Organ Preservation Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Organ Preservation Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Organ Preservation Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Organ Preservation Solutions include 21st Century Medicine, BioLife Solutions, Inc., BioTime, Inc., Bristol-Myers Squibb, Claris Lifesciences Limited, CryoLife, Inc., Dr. Franz Köhler Chemie, Lifeline Scientific and Teva Pharmaceutical Industries Ltd., among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Organ Preservation Solutions market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Organ Preservation Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Organ Preservation Solutions Market by Company
21st Century Medicine
BioLife Solutions, Inc.
BioTime, Inc.
Bristol-Myers Squibb
Claris Lifesciences Limited
CryoLife, Inc.
Dr. Franz Köhler Chemie
Lifeline Scientific
Teva Pharmaceutical Industries Ltd.
ToleroTech, Inc
XVIVO Perfusion AB
Organ Preservation Solutions Segment by Type
Viaspan
Custodial
siRNA Transplant Solutions
Others
Organ Preservation Solutions Segment by Application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
Organ Preservation Solutions Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organ Preservation Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Organ Preservation Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organ Preservation Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Organ Preservation Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Viaspan
- Custodial
- siRNA Transplant Solutions
- Others
Applications
- Hypothermic Perfusion Preservation (HPP)
- Static Cold Storage (SCS)
- Others
Companies covered
- 21st Century Medicine
- BioLife Solutions, Inc.
- BioTime, Inc.
- Bristol-Myers Squibb
- Claris Lifesciences Limited
- CryoLife, Inc.
- Dr. Franz Köhler Chemie
- Lifeline Scientific
- Teva Pharmaceutical Industries Ltd.
- ToleroTech, Inc
- XVIVO Perfusion AB
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Organ Preservation Solutions by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Viaspan
- 2.2.3 Custodial
- 2.2.4 siRNA Transplant Solutions
- 2.2.5 Others
- 2.3 Organ Preservation Solutions by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hypothermic Perfusion Preservation (HPP)
- 2.3.3 Static Cold Storage (SCS)
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Organ Preservation Solutions Breakdown Data by Type
- 3.1 Global Organ Preservation Solutions Historic Market Size by Type (2021-2026)
- 3.2 Global Organ Preservation Solutions Forecasted Market Size by Type (2027-2032)
4 Organ Preservation Solutions Breakdown Data by Application
- 4.1 Global Organ Preservation Solutions Historic Market Size by Application (2021-2026)
- 4.2 Global Organ Preservation Solutions Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Organ Preservation Solutions Market Perspective (2021-2032)
- 5.2 Global Organ Preservation Solutions Growth Trends by Region
- 5.2.1 Global Organ Preservation Solutions Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Organ Preservation Solutions Historic Market Size by Region (2021-2026)
- 5.2.3 Organ Preservation Solutions Forecasted Market Size by Region (2027-2032)
- 5.3 Organ Preservation Solutions Market Dynamics
- 5.3.1 Organ Preservation Solutions Industry Trends
- 5.3.2 Organ Preservation Solutions Market Drivers
- 5.3.3 Organ Preservation Solutions Market Challenges
- 5.3.4 Organ Preservation Solutions Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Organ Preservation Solutions Players by Revenue
- 6.1.1 Global Top Organ Preservation Solutions Players by Revenue (2021-2026)
- 6.1.2 Global Organ Preservation Solutions Revenue Market Share by Players (2021-2026)
- 6.2 Global Organ Preservation Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Organ Preservation Solutions Head Office and Area Served
- 6.4 Global Organ Preservation Solutions Players, Product Type & Application
- 6.5 Global Organ Preservation Solutions Manufacturers Established Date
- 6.6 Global Organ Preservation Solutions Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Organ Preservation Solutions Market Size (2021-2032)
- 7.2 North America Organ Preservation Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Organ Preservation Solutions Market Size by Country (2021-2026)
- 7.4 North America Organ Preservation Solutions Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Organ Preservation Solutions Market Size (2021-2032)
- 8.2 Europe Organ Preservation Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Organ Preservation Solutions Market Size by Country (2021-2026)
- 8.4 Europe Organ Preservation Solutions Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Organ Preservation Solutions Market Size (2021-2032)
- 9.2 Asia-Pacific Organ Preservation Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Organ Preservation Solutions Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Organ Preservation Solutions Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Organ Preservation Solutions Market Size (2021-2032)
- 10.2 South America Organ Preservation Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Organ Preservation Solutions Market Size by Country (2021-2026)
- 10.4 South America Organ Preservation Solutions Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Organ Preservation Solutions Market Size (2021-2032)
- 11.2 Middle East & Africa Organ Preservation Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Organ Preservation Solutions Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Organ Preservation Solutions Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 21st Century Medicine
- 12.1.1 21st Century Medicine Company Information
- 12.1.2 21st Century Medicine Business Overview
- 12.1.3 21st Century Medicine Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.1.4 21st Century Medicine Organ Preservation Solutions Product Portfolio
- 12.1.5 21st Century Medicine Recent Developments
- 12.2 BioLife Solutions, Inc.
- 12.2.1 BioLife Solutions, Inc. Company Information
- 12.2.2 BioLife Solutions, Inc. Business Overview
- 12.2.3 BioLife Solutions, Inc. Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.2.4 BioLife Solutions, Inc. Organ Preservation Solutions Product Portfolio
- 12.2.5 BioLife Solutions, Inc. Recent Developments
- 12.3 BioTime, Inc.
- 12.3.1 BioTime, Inc. Company Information
- 12.3.2 BioTime, Inc. Business Overview
- 12.3.3 BioTime, Inc. Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.3.4 BioTime, Inc. Organ Preservation Solutions Product Portfolio
- 12.3.5 BioTime, Inc. Recent Developments
- 12.4 Bristol-Myers Squibb
- 12.4.1 Bristol-Myers Squibb Company Information
- 12.4.2 Bristol-Myers Squibb Business Overview
- 12.4.3 Bristol-Myers Squibb Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.4.4 Bristol-Myers Squibb Organ Preservation Solutions Product Portfolio
- 12.4.5 Bristol-Myers Squibb Recent Developments
- 12.5 Claris Lifesciences Limited
- 12.5.1 Claris Lifesciences Limited Company Information
- 12.5.2 Claris Lifesciences Limited Business Overview
- 12.5.3 Claris Lifesciences Limited Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.5.4 Claris Lifesciences Limited Organ Preservation Solutions Product Portfolio
- 12.5.5 Claris Lifesciences Limited Recent Developments
- 12.6 CryoLife, Inc.
- 12.6.1 CryoLife, Inc. Company Information
- 12.6.2 CryoLife, Inc. Business Overview
- 12.6.3 CryoLife, Inc. Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.6.4 CryoLife, Inc. Organ Preservation Solutions Product Portfolio
- 12.6.5 CryoLife, Inc. Recent Developments
- 12.7 Dr. Franz Köhler Chemie
- 12.7.1 Dr. Franz Köhler Chemie Company Information
- 12.7.2 Dr. Franz Köhler Chemie Business Overview
- 12.7.3 Dr. Franz Köhler Chemie Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.7.4 Dr. Franz Köhler Chemie Organ Preservation Solutions Product Portfolio
- 12.7.5 Dr. Franz Köhler Chemie Recent Developments
- 12.8 Lifeline Scientific
- 12.8.1 Lifeline Scientific Company Information
- 12.8.2 Lifeline Scientific Business Overview
- 12.8.3 Lifeline Scientific Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.8.4 Lifeline Scientific Organ Preservation Solutions Product Portfolio
- 12.8.5 Lifeline Scientific Recent Developments
- 12.9 Teva Pharmaceutical Industries Ltd.
- 12.9.1 Teva Pharmaceutical Industries Ltd. Company Information
- 12.9.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 12.9.3 Teva Pharmaceutical Industries Ltd. Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.9.4 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Portfolio
- 12.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments
- 12.10 ToleroTech, Inc
- 12.10.1 ToleroTech, Inc Company Information
- 12.10.2 ToleroTech, Inc Business Overview
- 12.10.3 ToleroTech, Inc Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.10.4 ToleroTech, Inc Organ Preservation Solutions Product Portfolio
- 12.10.5 ToleroTech, Inc Recent Developments
- 12.11 XVIVO Perfusion AB
- 12.11.1 XVIVO Perfusion AB Company Information
- 12.11.2 XVIVO Perfusion AB Business Overview
- 12.11.3 XVIVO Perfusion AB Revenue in Organ Preservation Solutions Business (2021-2026)
- 12.11.4 XVIVO Perfusion AB Organ Preservation Solutions Product Portfolio
- 12.11.5 XVIVO Perfusion AB Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst